{"title":"脂肪间充质干细胞及其在治疗肾脏疾病中的作用","authors":"F. Dadras, F. Khoshjou","doi":"10.34172/jrip.2024.32244","DOIUrl":null,"url":null,"abstract":"Kidney diseases are universal and researchers are trying to figure out how to manage them. Meanwhile, stem cells are a promising source of therapy that has been considered for various kinds of illnesses. Here, we are going to present the newest studies allocated to the role of adipose-derived stem cells in the management of kidney diseases (e.g. acute and chronic kidney diseases, diabetic nephropathy, and rejection). By searching in PubMed, 34 paper related to the topic were reviewed. Various diseases and pathophysiologic aspects of them have been considered in their presentation, as well. Route of injection, combination therapy, and scaffolds are among the other subjects.","PeriodicalId":16950,"journal":{"name":"Journal of Renal Injury Prevention","volume":null,"pages":null},"PeriodicalIF":0.2000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Adipose derived mesenchymal stem cells and their role in management of kidney diseases\",\"authors\":\"F. Dadras, F. Khoshjou\",\"doi\":\"10.34172/jrip.2024.32244\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Kidney diseases are universal and researchers are trying to figure out how to manage them. Meanwhile, stem cells are a promising source of therapy that has been considered for various kinds of illnesses. Here, we are going to present the newest studies allocated to the role of adipose-derived stem cells in the management of kidney diseases (e.g. acute and chronic kidney diseases, diabetic nephropathy, and rejection). By searching in PubMed, 34 paper related to the topic were reviewed. Various diseases and pathophysiologic aspects of them have been considered in their presentation, as well. Route of injection, combination therapy, and scaffolds are among the other subjects.\",\"PeriodicalId\":16950,\"journal\":{\"name\":\"Journal of Renal Injury Prevention\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2024-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Renal Injury Prevention\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.34172/jrip.2024.32244\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Renal Injury Prevention","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jrip.2024.32244","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
Adipose derived mesenchymal stem cells and their role in management of kidney diseases
Kidney diseases are universal and researchers are trying to figure out how to manage them. Meanwhile, stem cells are a promising source of therapy that has been considered for various kinds of illnesses. Here, we are going to present the newest studies allocated to the role of adipose-derived stem cells in the management of kidney diseases (e.g. acute and chronic kidney diseases, diabetic nephropathy, and rejection). By searching in PubMed, 34 paper related to the topic were reviewed. Various diseases and pathophysiologic aspects of them have been considered in their presentation, as well. Route of injection, combination therapy, and scaffolds are among the other subjects.
期刊介绍：
The Journal of Renal Injury Prevention (JRIP) is a quarterly peer-reviewed international journal devoted to the promotion of early diagnosis and prevention of renal diseases. It publishes in March, June, September and December of each year. It has pursued this aim through publishing editorials, original research articles, reviews, mini-reviews, commentaries, letters to the editor, hypothesis, case reports, epidemiology and prevention, news and views and renal biopsy teaching point. In this journal, particular emphasis is given to research, both experimental and clinical, aimed at protection/prevention of renal failure and modalities in the treatment of diabetic nephropathy. A further aim of this journal is to emphasize and strengthen the link between renal pathologists/nephropathologists and nephrologists. In addition, JRIP welcomes basic biomedical as well as pharmaceutical scientific research applied to clinical nephrology. Futuristic conceptual hypothesis that integrate various fields of acute kidney injury and renal tubular cell protection are encouraged to be submitted.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
